Your browser doesn't support javascript.
loading
A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.
Jung, Chan-Hee; Rhee, Eun-Jung; Lee, Won-Young; Min, Kyung Wan; Shivane, Vyankatesh K; Sosale, Aravind R; Jang, Hak Chul; Chung, Choon Hee; Nam-Goong, Il Seong.
Afiliación
  • Jung CH; Department of Internal Medicine, Soonchunhyang Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon, South Korea.
  • Rhee EJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee WY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Min KW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Eulji General Hospital, Seoul, South Korea.
  • Shivane VK; Research Health Institute of Diabetes, Endocrinology and Metabolism, Mumbai, India.
  • Sosale AR; Diacon Hospital, Diabetes Care and Research Centre, Bangalore, India.
  • Jang HC; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Chung CH; Department of Endocrinology and Metabolism, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.
  • Nam-Goong IS; Department of Endocrinology and Metabolism, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, South Korea.
Diabetes Obes Metab ; 20(6): 1535-1541, 2018 06.
Article en En | MEDLINE | ID: mdl-29436761
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Fosfato de Sitagliptina / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Fosfato de Sitagliptina / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article País de afiliación: Corea del Sur